期刊文献+

醉茄素A诱导人胆囊癌GBC-SD细胞凋亡及其可能的机制 被引量:4

Apoptosis of human gallbladder carcinoma GBC-SD cells induced by withaferin A and its possible mechanism
原文传递
导出
摘要 目的:探讨醉茄素A体外诱导人胆囊癌GBC-SD细胞凋亡及其可能的分子机制。方法:以不同浓度醉茄素A处理人胆囊癌GBC-SD细胞后,CCK-8法检测GBC-SD细胞的增殖情况,Hoechst33258荧光染色和透射电子显微镜下观察GBC-SD细胞的凋亡形态和超微结构变化,FCM法检测GBC-SD细胞的凋亡率和周期分布,蛋白质印迹法检测GBC-SD细胞中多聚ADP核糖聚合酶[poly(ADP-ribose)polymerase,PARP]、cyclin D1、cyclin B1、细胞周期蛋白依赖性激酶1(cyclin-dependent kinase1,Cdk1)和p21蛋白的表达。结果:醉茄素A对GBC-SD细胞的增殖有明显的抑制作用(P<0.05),并且这种抑制作用呈浓度和时间依赖性。醉茄素A能诱导GBC-SD细胞出现典型的凋亡形态学改变及超微结构变化。与未加药的阴性对照组比较,醉茄素A作用后GBC-SD细胞的凋亡率明显增加(P<0.01),细胞阻滞于G2/M期,细胞周期相关蛋白cyclin D1和Cdk1的表达下调(P<0.05),cyclin B1和p21蛋白的表达上调(P<0.05),PARP蛋白剪切体增多(P<0.05)。结论:醉茄素A可能通过下调细胞周期相关蛋白cyclin D1、Cdk1的表达和上调cyclin B1、p21的表达,使GBC-SD细胞阻滞于G2/M期,进而抑制GBC-SD细胞的增殖并诱导其凋亡。 Objective: To investigate WA (withaferin A)-induced apoptosis of human gallbladder carcinoma GBC-SD cells in vitro and to explore its possible mechanism. Methods: The proliferation of GBC-SD cells after treatment with different concentrations of WA was detected by CCK-8 (cell counting kit-8) assay. The apoptotic morphology and super-microstructural changes were observed by using Hoechst 33258 fluorescent staining and under a transmission electron microscope. The apoptosis rate and the cell cycle distribution of GBC-SD cells were detected by flow cytometry. The expressions of PARP [poly (ADP-ribose) polymerase], cyclin D1, cyclin B1, Cdkl (cyclin-dependent kinase 1) and p21 in GBC- SD cells were detected by Western blotting. Results: WA could significantly inhibit the proliferation of GBC-SD cells in a dose- and time-dependent manner (P 〈 0.05). WA could also induce typical apoptotic morphological and super-microstructural changes of GBC-SD cells. As compared with the GBC-SD cells without WA treatment, WA could significantly increase the percentage of apoptotic GBC-SD cells (P 〈 0.01) and caused the cell arrest at G2/M phase. WA could also significantly down-regulate the expression levels of cyclin D1 and Cdkl proteins (P 〈 0.05), whereas up-regulate the expression levels of cyclin B1 and p21 proteins (P 〈 0.05) and promote the cleavage of PARP (P 〈 0.05). Conclusion: WA could induce the GBC-SD cell arrest at G2/M phase by down-regulating the expression levels of cyclin D1 and Cdkl and up-regulating the expression levels of cyclin B1 and p21. These effects may lead to the suppression of cellular proliferation and the aDoDtosis of GBC-SD cells.
出处 《肿瘤》 CAS CSCD 北大核心 2013年第6期502-508,共7页 Tumor
关键词 胆囊肿瘤 细胞周期 细胞凋亡 醉茄素A 细胞 GBC—SD Gallbladder neoplasms Cell cycle Apoptosis Withaferin A Cell, GBC-SD
  • 相关文献

参考文献15

  • 1ZHU A X, HONG T S, HEZEL A F, et al. Current management of gallbladder carcinoma[J]. Oncologist, 2010, 15(2): 168-181.
  • 2MISRA L, LAL P, SANGWAN R S, et al. Unusually sulfated and oxygenated steroids from Withania somnifera[J]. Phytochemistry, 2005, 66(23):2702-2707.
  • 3VANDEN BERGHE W, SABBE L, KAILEH M, et al. Molecular insight in the multifunctional activities of Withaferin A[J]. Biochem Pharmacol, 2012, 84(10):1282-1291.
  • 4李东华,王占民,刘军,刘博,吴小鹏.人胆囊癌细胞系GBC-SD的多药耐药机制[J].中华实验外科杂志,2003,20(11):995-997. 被引量:6
  • 5CHOU T C. Preclinical versus clinical drug combination studiesUJ. Leuk Lymphoma, 2008, 49(11 ):2059-2080.
  • 6ROMITI A, D'ANTONIO C, ZULLO A, et al. Chemotherapy for the biliary tract cancers: moving toward improved survival time[J].) Gastrointest Cancer, 2012, 43(3):396-404.
  • 7钱隽,王漪璇,郁韵秋,李进.注射用紫杉醇脂质体与紫杉醇注射液在肿瘤患者中的药动学比较[J].肿瘤,2011,31(12):1103-1107. 被引量:31
  • 8MOHAN R, HAMMERS H j, BARGAGNA-MOHAN P, et al. Withaferin A is a potent inhibitor of angiogenesis(J]. Angiogenesis, 2004, 7(2):115-122.
  • 9ZHANG X, SAMADI A K, ROBY K F, et al. Inhibition of cell growth and induction of apoptosis in I ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin AUJ. Gynecol Oncol, 2012, 124(3):606-612.
  • 10MUNAGALA R, KAUSAR H, MUNjAL C, et al. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cellsljl. Carcinogenesis, 2011, 32(11): 1697 -1 705.

二级参考文献16

  • 1周卫,翁帼英,陈文忠,庄翌,傅晓阳,程光.紫杉醇脂质体在大鼠体内的组织分布[J].中国药学杂志,2005,40(18):1402-1404. 被引量:54
  • 2杨爱珍,李军,徐海军,陈惠英.紫杉醇脂质体的体内外抗肿瘤作用研究[J].中国肿瘤,2006,15(12):862-864. 被引量:17
  • 3TENTIJE A J,VERWEIJ J,LOOS W J,et al.Pharmacological effects of formulation vehicles:implications for cancer chemotherapy[J].Clin Pharmacokinet,2003,42(7):665-685.
  • 4SAMAD A,SULTANA Y,AQIL M.Liposomal Drug Delivery Systems:An Update Review[J].Curr Drug Deliv,2007,4(4):297-305.
  • 5MAEDA H,FANG J,INUTSUKA T,et al.Vascular permeability enhancement in solid tumors:various factors,mechanisms involved and its implications[J].Int Immunopharmacol,2003,3 (3):319-328.
  • 6HOFHEINZ R D,GNAD-VOGT S U,BEYER U,et al.Liposomal encapsulated anti-cancer drugs[J].Anticancer Drugs,2005,16(7):691-707.
  • 7Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer, 2002, 2: 48-58.
  • 8Johnstone RW, Ruefli AA, Tainton K_M, et al. A role for P-glycoprotein in regulating cell death. Leuk Lymphoma, 2000, 38:1-11.
  • 9Ishikawa T, Muller M, Klunemaim- C, et al. ATP-dependent primary active transport d cysteinyl leukotrienes across liver eanalicular membranee. J Biol Chem, 1990, 265:19279-19284.
  • 10Scheffer GL, Schroeijers AB, Izquierdo MA, et al. Lung resistance related protein/major vault protein and vaults in multidrug resistant cancer.Curt Opin Oncol, 2000, 12: 550-556.

共引文献35

同被引文献50

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部